Impact of medical treatment of endometriosis on bone mass
- 1 February 1993
- journal article
- review article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 168 (2) , 674-684
- https://doi.org/10.1016/0002-9378(93)90516-l
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Bone density in women receiving depot medroxyprogesterone acetate for contraception.BMJ, 1991
- Gonadotropin releasing hormone agonist therapy and its effect on bone massGynecological Endocrinology, 1991
- THE EFFECTS OF NAFARELIN AND DANAZOL ON VERTEBRAL TRABECULAR BONE MASS IN PATIENTS WITH ENDOMETRIOSISClinical Endocrinology, 1990
- A Comparison of the Skeletal Effects of Goserelin and Danazol in Premenopausal Women with EndometriosisHormone Research, 1989
- Estrogen Binding, Receptor mRNA, and Biologic Response in Osteoblast-Like Osteosarcoma CellsScience, 1988
- Administration of Nasal Nafarelin as Compared with Oral Danazol for EndometriosisNew England Journal of Medicine, 1988
- Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.BMJ, 1987
- The proportion of trabecular bone in human vertebraeJournal of Bone and Mineral Research, 1987
- LHRH ANALOGUES AND BONE LOSSThe Lancet, 1987
- Steroid Receptors in OsteoblastsPublished by Wolters Kluwer Health ,1980